National Healthcare (NHC) Cash & Equivalents (2010 - 2026)

National Healthcare (NHC) has reported Cash & Equivalents for 17 consecutive years, with $85.5 million the latest figure, recorded in Q1 2026.

• Cash & Equivalents for Q1 2026 came in at $85.5 million, down 5.38% year-over-year; the trailing twelve-month figure through Mar 2026 was $85.5 million (down 5.38% YoY), and the FY2025 annual result was $18.1 million, down 76.2% from the prior year.
• Cash & Equivalents was $85.5 million for Q1 2026 at National Healthcare, up from $18.1 million in the prior quarter.
• Over five years, Cash & Equivalents peaked at $136.2 million in Q2 2024 and troughed at $18.1 million in Q4 2025.
• Average Cash & Equivalents over 5 years is $82.0 million, with a median of $84.8 million recorded in 2024.
• Year-over-year, Cash & Equivalents soared 125.34% in 2023 and sank 76.2% in 2025.
• Over 5 years, Cash & Equivalents stood at $58.7 million in 2022, then soared by 82.51% to $107.1 million in 2023, then retreated by 28.91% to $76.1 million in 2024, then tumbled by 76.2% to $18.1 million in 2025, then surged by 372.05% to $85.5 million in 2026.
• Per Business Quant data, the three most recent Cash & Equivalents figures were $85.5 million in Q1 2026, $18.1 million in Q4 2025, and $130.6 million in Q3 2025.